NEW YORK – Twist Bioscience reported after the close of the market on Thursday that its first quarter revenues in fiscal year 2020 increased 49 percent year over year.
Separately, the firm announced that it had reached a settlement agreement with Agilent Technologies over an intellectual property lawsuit Agilent had filed in 2016. Earlier in the day, speculation about an impending settlement had led to a sharp rise in Twist's share price.